Gland Pharma IPO - Grey Market, GMP & Reviews

IPO Details

Issue Date 09/11 - 11/11
Issue Size ₹6479.55 Cr
Issue Price ₹1490 - 1500
Market Lot 10 Shares
Shares on Offer 34,863,635
Registrar Link Intime
GMP ₹160 - 170
Kostak ₹800
Subject to Sauda ₹1350-1400
Listing Date 20 Nov 2020
Listing Price ₹1701
Listing Gain% 13.04

About Gland Pharma Limited

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. They operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. They are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

A holistic objective of dispensing health through a portfolio of injectable products across various therapeutic segments and delivery systems, has helped us expand to seven manufacturing facilities in India, with a capacity of approximately 750 million units. These include ftheir facilities with 22 production lines for finished formulations and three Active Pharmaceutical Ingredient (API) facilities. Their products are produced at world-class manufacturing facilities and conform to global compliance, regulatory and quality specifications.

They are present in sterile injectables, oncology and ophthalmic segments, and focus on complex injectables including NCE-1s, First-to-File products and 505(b)(2) filings. Their products are currently delivered via liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops; and efforts are underway to augment additional manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products. They are also in the process of including new delivery systems such as pens and cartridges into their product portfolio.

Their ethos at work is to consistently focus on meeting diverse injectable needs with high-quality products at attractive price points. On this strong plinth of looking ahead, they have successfully and repeatedly harnessed their R&D expertise in synthesizing complex molecules to produce complex injectables. Enabling us to develop niche products for diverse markets worldwide.

Company Promoters

Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters.

Objects of the Issue:

The net proceeds from the IPO will be used for the following purposes:

  1. To finance the incremental working capital requirements of the Company
  2. To meet funding requirements for capital expenditure requirements
  3. To meet the general corporate purposes

Company Financials

Particulars 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets (In ₹ Millions) 40,860.39 35,235.49 29,294.68
Total Revenue (In ₹ Millions) 27,724.08 21,297.67 16,716.82
Profit After Tax (PAT) (In ₹ Millions) 7,728.58 4,518.56 3,210.51

Gland Pharma Limited IPO Reviews

  • Rating: 
  • Recommendation:

Subscription Details

Date & Time QIB NII RII Total
Day 1 - 09 Nov 2020
Day 2 - 10 Nov 2020
Day 3 - 11 Nov 2020

Allotment Status

Please click the link below to check the IPO allotment status.

IPO Allotment Status

Gland Pharma Limited IPO FAQs

  1. When will Gland Pharma Limited IPO open?

    Gland Pharma Limited IPO will open on 09/11 and close on 11/11.

  2. What is the listing date of Gland Pharma Limited IPO?

    Gland Pharma Limited IPO will list on 20 Nov 2020.

  3. What is the offer price of Gland Pharma Limited IPO?

    The offer price of Gland Pharma Limited IPO is ₹1490 - 1500.

  4. What is the lot size of Gland Pharma Limited IPO?

    The lot size of Gland Pharma Limited IPO is 10.

  5. What is the Grey Market Premium (GMP) price of Gland Pharma Limited IPO?

    The Grey Market Premium (GMP) price of Gland Pharma Limited IPO is ₹160 - 170.

  6. What is the Kostak price of Gland Pharma Limited IPO?

    The Kostak price of Gland Pharma Limited IPO is ₹800.

  7. What is the Subject to Sauda price for Gland Pharma Limited IPO?

    The Subject to Sauda price for Gland Pharma Limited IPO is ₹1350-1400.

Gland Pharma Limited IPO Review/Comments

Please Leave Your Message